| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 1, 2004
From the Hemostasia Unit (A.S., J.M., I.T., A.O., R.F., J.M.S., J.C.S., J.F.), Department of Hematology; and the Stroke Unit (R.B., J. M.-F.), Department of Neurology, Universitat Autónoma de Barcelona, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. * To whom correspondence should be addressed. E-mail: msantamaria{at}hsp.santpau.es.
Background and Purpose--Ischemic stroke (IS) is a complex disease that involves genetic and environmental factors. In a family-based study (the Genetic Analysis of Idiopathic Thrombophilia [GAIT] Project) that included a genome-wide scan, we demonstrated that a common polymorphism (46 C Methods--We studied 436 individuals: 205 diagnosed with IS and 231 age-gender-ethnic control subjects. We measured Factor VIIIc, fibrinogen, and Factor XIIc levels, and we genotyped the 46 C Results--There were 91 women and 114 men in the IS group and 109 women and 122 men in the control group. We confirmed our previous observation that individuals with different genotypes for the 46 C Conclusions--This study suggests that the 46 C
Revised on April 13, 2004
Accepted on April 29, 2004
Homozygosity of the T Allele of the 46 C
Amparo Santamaría MD*;
T Polymorphism in the F12 Gene Is a Risk Factor for Ischemic Stroke in the Spanish Population
T) in the exon 1 of the F12 gene jointly influences variability of plasma Factor XII levels and susceptibility to thrombotic disease. We have investigated the risk of IS related to this polymorphism in a case-control study.
T polymorphism in the F12 gene.
T polymorphism showed significant differences in Factor XIIc levels. Most importantly, the mutated T allele in the homozygous state (genotype T/T) was associated with an increased risk of IS with an adjusted odds ratio of 4.1 (95% CI, 1.1 to 15.9).
T polymorphism is a genetic risk factor for IS in the Spanish population. In addition, our results confirm that the use of genetic linkage studies along with a case-control association study is an extremely valuable approach for identifying DNA variants that affect complex diseases.
This article has been cited by other articles:
![]() |
K. H. Reuner, E. Jenetzky, A. Aleu, F. Litfin, P. Mellado, M. Kloss, E. Juttler, A. J. Grau, H. Rickmann, H. Patscheke, et al. Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis Neurology, January 8, 2008; 70(2): 129 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gailani and T. Renne Intrinsic Pathway of Coagulation and Arterial Thrombosis Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2507 - 2513. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Renne, M. Pozgajova, S. Gruner, K. Schuh, H.-U. Pauer, P. Burfeind, D. Gailani, and B. Nieswandt Defective thrombus formation in mice lacking coagulation factor XII J. Exp. Med., July 18, 2005; 202(2): 271 - 281. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |